An Exploratory Study of High-dose Glivec in Patients With CML-CP Using Molecular Endpoints
Clinical trial NCT01216085 · COMPLETED
Trial details
- NCT number
- NCT01216085
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2011-07-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.